Alterations in the RB, p16, and Cyclin D1 Cell Cycle Control Pathway in Osteosarcomas
- 1 January 2000
- journal article
- Published by Taylor & Francis in Pediatric Pathology & Molecular Medicine
- Vol. 19 (5) , 377-389
- https://doi.org/10.1080/15513810009168646
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- CDKN2A Gene Deletions and Loss of p16 Expression Occur in Osteosarcomas That Lack RB AlterationsThe American Journal of Pathology, 1998
- Alterations of thep53, Rb andMDM2 genes in osteosarcomsZeitschrift für Krebsforschung und Klinische Onkologie, 1996
- Loss of Heterozygosity and Microsatellite Instability at the Retinoblastoma Locus in OsteosarcomasDiagnostic Molecular Pathology, 1996
- Alterations of the p15, p16, and p18 genes in osteosarcomaCancer Genetics and Cytogenetics, 1996
- Cytogenetic aberrations in osteosarcomasCancer Genetics and Cytogenetics, 1994
- Aberrant RB gene expression in routinely processed, archival tumor tissues determined by three different anti‐RB antibodiesInternational Journal of Cancer, 1994
- Retinoblastoma protein monoclonal antibodies with novel characteristicsJournal of Immunological Methods, 1994
- Complete association of loss of heterozygosity of chromosomes 13 and 17 in osteosarcomaCancer Genetics and Cytogenetics, 1991
- Preferential mutation of paternally derived RB gene as the initial event in sporadic osteosarcomaNature, 1989
- Osteosarcoma and retinoblastoma: a shared chromosomal mechanism revealing recessive predisposition.Proceedings of the National Academy of Sciences, 1985